Agilent Technologies, Inc. (NYSE:A) had its price objective increased by Barclays PLC from $67.00 to $71.00 in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage currently has an overweight rating on the medical research company’s stock.

Several other analysts also recently weighed in on A. BidaskClub downgraded Agilent Technologies from a strong-buy rating to a buy rating in a research report on Monday, July 31st. Jefferies Group LLC reiterated a buy rating and issued a $66.00 price objective on shares of Agilent Technologies in a research report on Wednesday, August 9th. J P Morgan Chase & Co reiterated an overweight rating and issued a $70.00 price objective on shares of Agilent Technologies in a research report on Wednesday, August 16th. Bank of America Corporation reiterated an equal weight rating on shares of Agilent Technologies in a research report on Tuesday, August 15th. Finally, Janney Montgomery Scott boosted their price objective on Agilent Technologies from $65.00 to $70.00 and gave the company a buy rating in a research report on Wednesday, August 16th. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The stock has a consensus rating of Buy and an average price target of $68.20.

Shares of Agilent Technologies (NYSE A) opened at $68.69 on Tuesday. The stock has a market capitalization of $21,720.00, a P/E ratio of 29.50, a price-to-earnings-growth ratio of 2.76 and a beta of 1.28. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.30 and a quick ratio of 2.76. Agilent Technologies has a 52 week low of $42.92 and a 52 week high of $70.81.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.62 by $0.05. The business had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.17 billion. Agilent Technologies had a return on equity of 15.05% and a net margin of 14.89%. Agilent Technologies’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.59 earnings per share. equities analysts expect that Agilent Technologies will post 2.57 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Barclays PLC Raises Agilent Technologies, Inc. (A) Price Target to $71.00” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/24/barclays-plc-raises-agilent-technologies-inc-a-price-target-to-71-00.html.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd will be issued a dividend of $0.149 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date is Friday, December 29th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio is currently 25.24%.

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 22,481 shares of the stock in a transaction on Monday, November 20th. The stock was sold at an average price of $70.00, for a total value of $1,573,670.00. Following the completion of the transaction, the chief executive officer now owns 327,882 shares in the company, valued at $22,951,740. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Boon Hwee Koh sold 4,500 shares of the stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $63.63, for a total value of $286,335.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 107,709 shares of company stock valued at $7,195,576.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Jennison Associates LLC purchased a new stake in shares of Agilent Technologies in the second quarter worth $212,000. Commerce Bank purchased a new stake in shares of Agilent Technologies in the second quarter worth $1,242,000. Delta Lloyd Asset Management N.V. purchased a new stake in shares of Agilent Technologies in the second quarter worth $2,026,000. Prudential Financial Inc. grew its stake in shares of Agilent Technologies by 2.5% in the second quarter. Prudential Financial Inc. now owns 457,503 shares of the medical research company’s stock worth $27,134,000 after acquiring an additional 11,020 shares during the last quarter. Finally, Cipher Capital LP grew its stake in shares of Agilent Technologies by 18.1% in the second quarter. Cipher Capital LP now owns 89,523 shares of the medical research company’s stock worth $5,309,000 after acquiring an additional 13,703 shares during the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Stock Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related stocks with our FREE daily email newsletter.